Name | 6-Chloro-3-methyluracil |
Synonyms | 3-METHYL-6-CHLOROURACI 6-Chloro-3-Methyuracil 6-Chloro-3-methyluracil 3-Methyl-6-chlorouracil 3-METHYL-6-CHLOROURACIL 6-CHLORO-3-METHYLURACIL 6-Chloro-3-dimethyl uracil 6-chloro-3-methylpyrimidine-2,4(1H,3H)-dione 6-chloro-3-methyl-2,4(1H,3H)-pyrimidinedione |
CAS | 4318-56-3 |
EINECS | 610-113-2 |
InChI | InChI=1/C5H5ClN2O2/c1-8-4(9)2-3(6)7-5(8)10/h2H,1H3,(H,7,10) |
InChIKey | SGLXGFAZAARYJY-UHFFFAOYSA-N |
Molecular Formula | C5H5ClN2O2 |
Molar Mass | 160.56 |
Density | 0,896 gr/cm |
Melting Point | 278-280°C (dec.) |
Boling Point | 268.7°C at 760 mmHg |
Flash Point | 116.3°C |
Vapor Presure | 0.00101mmHg at 25°C |
Appearance | Powder |
Color | White to Almost white |
BRN | 511456 |
pKa | 7.16±0.40(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
Refractive Index | 1.58 |
MDL | MFCD01074837 |
Physical and Chemical Properties | Melting Point: 278-280°C (dec.) |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
UN IDs | UN 1992 |
WGK Germany | 3 |
HS Code | 29335990 |
Hazard Note | Irritant |
Uses | 6-chloro-3-methyluracil has been used as a synthesis of antibacterial agents as an inhibitor of Helicobacter pylori glutamate racemase. 6-chloro-3-methyluracil Chinese alias: 6-chloro-3-methyluracil; 3-methyl-6-chlorouracil, white crystalline powder, used as an intermediate for the treatment of type 2 diabetes drug alogliptin benzoate; alogliptin intermediate. |
Application | 6-chloro-3-methyluracil, also known as 6-chloro-3-methyluracil, has a structure of formula I, it is an important intermediate for synthetic phosphodiesterase inhibitors, cystic fiber transmembrane transport regulators, chloride channel activators, adenosine receptor antagonists, antispasmodic drugs, nootropic drugs, oral drugs for the treatment of asthma, DPP-4 inhibitors, etc. For example, it is the synthesis of 3, 7-dihydroxypurin-2, 6-diketone drugs with formula II structure, and pyrazolo with formula III structure [3,4-d] An important intermediate of pyrimidine diketones and pyrimidine diketones with the structure of formula IV. |